We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.2B
AUM Growth
+$531M
Cap. Flow
-$116M
Cap. Flow %
-0.27%
Top 10 Hldgs %
19.93%
Holding
2,596
New
336
Increased
982
Reduced
987
Closed
267

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$560M
2
AMZN icon
Amazon
AMZN
+$499M
3
TSLA icon
Tesla
TSLA
+$412M
4
ADBE icon
Adobe
ADBE
+$411M
5
DHR icon
Danaher
DHR
+$394M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$449M
2
BMY icon
Bristol-Myers Squibb
BMY
+$430M
3
AVGO icon
Broadcom
AVGO
+$394M
4
CRWD icon
CrowdStrike
CRWD
+$354M
5
WFC icon
Wells Fargo
WFC
+$336M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 15.51%
3 Financials 15.33%
4 Consumer Discretionary 12.68%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHL
2301
DELISTED
Achilles Therapeutics
ACHL
$39K ﹤0.01%
34,200
+11,800
+53% +$12.2K
ADAP
2302
DELISTED
Adaptimmune Therapeutics
ADAP
$38.1K ﹤0.01%
70,735
+58,787
+492% +$42.8K
AZUL
2303
DELISTED
Azul
AZUL
$37.4K ﹤0.01%
22,400
-17,600
-44% -$45.9K
BCAB icon
2304
BioAtla
BCAB
$5.48M
$36.4K ﹤0.01%
1,230
-611
-33% -$51.3K
ACIU icon
2305
AC Immune
ACIU
$226M
$36.2K ﹤0.01%
+13,410
New +$41.9K
ATAI icon
2306
AtaiBeckley Inc
ATAI
$2.66B
$35.5K ﹤0.01%
+26,700
New +$35.5K
VTGN icon
2307
VistaGen Therapeutics
VTGN
$9.79M
$35.5K ﹤0.01%
+12,032
New +$33.9K
NOVA
2308
DELISTED
Sunnova Energy
NOVA
$35.3K ﹤0.01%
+10,300
New +$51.6K
HLLY icon
2309
Holley
HLLY
$317M
$34.4K ﹤0.01%
11,400
-8,900
-44% -$24.9K
GSIT icon
2310
GSI Technology
GSIT
$214M
$33.3K ﹤0.01%
+11,000
New +$34.6K
EAF icon
2311
GrafTech
EAF
$167M
$32.9K ﹤0.01%
+1,900
New +$35.4K
LPL icon
2312
LG Display
LPL
$3B
$32.2K ﹤0.01%
+10,500
New +$37K
ZURA icon
2313
Zura Bio
ZURA
$517M
$32K ﹤0.01%
+12,800
New +$45.6K
SKYE icon
2314
Skye Bioscience
SKYE
$20.6M
$31.7K ﹤0.01%
+11,200
New +$46.8K
VOR icon
2315
Vor Biopharma
VOR
$1.14B
$30.5K ﹤0.01%
1,375
-1,140
-45% -$18.9K
MASS icon
2316
908 Devices
MASS
$320M
$29.7K ﹤0.01%
+13,500
New +$38.7K
WKSP icon
2317
Worksport
WKSP
$9.34M
$29K ﹤0.01%
+3,150
New +$22.3K
LAB icon
2318
Standard BioTools
LAB
$344M
$24.7K ﹤0.01%
14,132
+300
+2% +$559
RJET
2319
Republic Airways Holdings
RJET
$1B
$23.8K ﹤0.01%
1,367
-46
-3% -$712
AP icon
2320
Ampco-Pittsburgh
AP
$164M
$23.2K ﹤0.01%
11,100
-200
-2% -$380
PXLW icon
2321
Pixelworks
PXLW
$36.9M
$22.9K ﹤0.01%
2,617
-2,733
-51% -$24.8K
NIU
2322
Niu Technologies
NIU
$198M
$20.2K ﹤0.01%
11,300
-32,800
-74% -$70.6K
NOTE
2323
DELISTED
FiscalNote
NOTE
$17.8K ﹤0.01%
1,383
+8
+0.6% +$97
SBDS
2324
DELISTED
Solo Brands Inc
SBDS
$17.3K ﹤0.01%
+380
New +$18.8K
VXRT
2325
DELISTED
Vaxart
VXRT
$16.4K ﹤0.01%
+24,700
New +$17.2K

Similar funds

Two Sigma Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Two Sigma Advisers held 2,596 positions worth $43.2B, up 1.2% from $42.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Two Sigma Advisers's Q4 2024 filing shows 336 new, 982 increased, 987 reduced and 267 closed positions. Its largest new stake was Intel: 14,451,450 shares worth $290M. The largest sale was Micron Technology, an estimated $449M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Advisers's largest Q4 2024 buy was Intel: 14,451,450 shares worth $290M.
  • Two Sigma Advisers added most to Meta Platforms (Facebook) in Q4 2024, an estimated $560M increase.
  • Two Sigma Advisers's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $449M.
  • Two Sigma Advisers fully exited Wells Fargo in Q4 2024, selling an estimated $336M.
  • Two Sigma Advisers's ten largest holdings make up 20% of its $43.2B portfolio in Q4 2024.
  • Two Sigma Advisers opened 336 new positions and closed 267 in Q4 2024.
  • Two Sigma Advisers's portfolio value rose 1.2% quarter-over-quarter to $43.2B.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.